hiv/aids
epidemiology of hiv/aids
timeline of hiv/aids
hiv/aids in the united states
aids (disambiguation)
list of countries by hiv/aids adult prevalence rate
hiv/aids in africa
hiv/aids denialism
aids (computer virus)
hiv/aids research
hiv
hiv/aids
epidemiology of hiv/aids
subtypes of hiv
history of hiv/aids
hiv (disambiguation)
diagnosis of hiv/aids
list of countries by hiv/aids adult prevalence rate
hiv/aids in africa
management of hiv/aids
tb
tuberculosis
tampa bay rays
terabyte
socata tb family
multi-drug-resistant tuberculosis
tuberculosis radiology
tuberculosis in india
directly observed treatment, short-course
tb alert
cancer
breast cancer
colorectal cancer
lung cancer
pancreatic cancer
not cancer
cancer (astrology)
prostate cancer
esophageal cancer
stomach cancer
bipolar disorder
bipolar
bipolar ii disorder
bipolarity
bipolar i disorder
bipolar junction transistor
list of people with bipolar disorder
bipolar neuron
schizoaffective disorder
retina bipolar cell
mental disorder
list of mental disorders
causes of mental disorders
classification of mental disorders
bipolar disorder
history of mental disorders
mental disorders and gender
diagnostic and statistical manual of mental disorders
personality disorder
treatment of mental disorders
brain tumor
list of people with brain tumors
cerebral edema
canine brain tumors
glioblastoma
meningioma
neurosurgery
griffith r. harsh
barrow neurological institute
atypical teratoid rhabdoid tumor
human immunodeficiency virus
human immunodeficiency virus infection with infectious mononucleosis-like syndrome
feline immunodeficiency virus
acquired immune deficiency syndrome
simian immunodeficiency virus
human immunodeficiency virus infection with acute lymphadenitis
fear of contracting human immunodeficiency virus infection
human immunodeficiency virus centers for disease control and prevention category a3

human immunodeficiency virus centers for disease control and prevention category b3

human immunodeficiency virus centers for disease control and prevention category c1

human immunodeficiency virus centers for disease control and prevention category c2

human immunodeficiency virus centers for disease control and prevention category c3

human immunodeficiency virus world health organization class iv

bovine immunodeficiency virus
audiovisual aids operator
fully mobile
human immunodeficiency virus antibody test
notification of acquired immune deficiency syndrome
human immunodeficiency virus screening
mobility aid
use of aids for daily life
use of kitchen aids
use of bathroom aids
use of work aids
use of indoor mobility aids
human aid to communication
provision of aids to daily living
sharing of sex aids
acquired immune deficiency syndrome-related nephropathy
aids for severely handicapped
human immunodeficiency virus risk lifestyle
acquired immunodeficiency syndrome risk behavior knowledge test
fear of acquired immunodeficiency syndrome scale
learning development aids - handwriting assessment
congenital acquired immune deficiency syndrome
use of memory retrieval aids
ability to mobilize using mobility aids
able to mobilize using mobility aids
unable to mobilize using mobility aids
does mobilize using aids
does not mobilize using mobility aids
difficulty mobilizing using mobility aids
handicapped aids
external memory aids training
aids to daily living
finding related to ability to mobilize using mobility aids
finding of use of memory retrieval aids
human immunodeficiency virus infection with aseptic meningitis
acquired immunodeficiency syndrome clinical trial group
pediatric acquired immunodeficiency syndrome clinical trial group
leukoplakia of tongue associated with human immunodeficiency virus disease
hairy leukoplakia of tongue associated with human immunodeficiency virus disease
neutropenia associated with acquired immunodeficiency syndrome
assistive device education
acquired immunodeficiency syndrome-associated disorder
abnormal weight loss associated with acquired immunodeficiency syndrome
acute endocarditis associated with acquired immunodeficiency syndrome
myocarditis associated with acquired immunodeficiency syndrome
agranulocytosis associated with acquired immunodeficiency syndrome
anemia associated with acquired immunodeficiency syndrome
acquired hemolytic anemia associated with acquired immunodeficiency syndrome
aplastic anemia associated with acquired immunodeficiency syndrome
retinopathy associated with acquired immunodeficiency syndrome
blindness associated with acquired immunodeficiency syndrome
cachexia associated with acquired immunodeficiency syndrome
candidiasis of mouth associated with acquired immunodeficiency syndrome
central nervous disorder associated with acquired immunodeficiency syndrome
central nervous system demyelinating disease associated with acquired immunodeficiency syndrome
myelopathy associated with acquired immunodeficiency syndrome
coccidioidomycosis associated with acquired immunodeficiency syndrome
cryptococcosis associated with acquired immunodeficiency syndrome
disseminated candidiasis associated with acquired immunodeficiency syndrome
encephalopathy associated with acquired immunodeficiency syndrome
dementia associated with acquired immunodeficiency syndrome
encephalitis associated with acquired immunodeficiency syndrome
encephalomyelitis associated with acquired immunodeficiency syndrome
organic brain syndrome associated with acquired immunodeficiency syndrome
organic dementia associated with acquired immunodeficiency syndrome
presenile dementia associated with acquired immunodeficiency syndrome
primary lymphoma of brain associated with acquired immunodeficiency syndrome
progressive multifocal leukoencephalopathy associated with acquired immunodeficiency syndrome
subacute adenoviral encephalitis associated with acquired immunodeficiency syndrome
failure to thrive in infant associated with acquired immunodeficiency syndrome
fatigue associated with acquired immunodeficiency syndrome
hematopoietic system disease associated with acquired immunodeficiency syndrome
hepatomegaly associated with acquired immunodeficiency syndrome
herpes zoster associated with acquired immunodeficiency syndrome
histoplasmosis associated with acquired immunodeficiency syndrome
ill-defined intestinal infection associated with acquired immunodeficiency syndrome
infectious gastroenteritis associated with acquired immunodeficiency syndrome
noninfectious gastroenteritis associated with acquired immunodeficiency syndrome
infective arthritis associated with acquired immunodeficiency syndrome
intestinal malabsorption associated with acquired immunodeficiency syndrome
low vision associated with acquired immunodeficiency syndrome
malaise associated with acquired immunodeficiency syndrome
malignant neoplasm associated with acquired immunodeficiency syndrome
kaposi's sarcoma associated with acquired immunodeficiency syndrome
reticulosarcoma associated with acquired immunodeficiency syndrome
microsporidiosis associated with acquired immunodeficiency syndrome
mycobacteriosis associated with acquired immunodeficiency syndrome
tuberculosis associated with acquired immunodeficiency syndrome
myelitis associated with acquired immunodeficiency syndrome
neuralgia associated with acquired immunodeficiency syndrome
neuritis associated with acquired immunodeficiency syndrome
radiculitis associated with acquired immunodeficiency syndrome
nocardiosis associated with acquired immunodeficiency syndrome
nutritional deficiency associated with acquired immunodeficiency syndrome
pneumocystosis associated with acquired immunodeficiency syndrome
pneumonia associated with acquired immunodeficiency syndrome
bacterial pneumonia associated with acquired immunodeficiency syndrome
pneumococcal pneumonia associated with acquired immunodeficiency syndrome
candidiasis of lung associated with acquired immunodeficiency syndrome
viral pneumonia associated with acquired immunodeficiency syndrome
polyneuropathy associated with acquired immunodeficiency syndrome
respiratory disorder associated with acquired immunodeficiency syndrome
dyspnea associated with acquired immunodeficiency syndrome
retinal vascular changes associated with acquired immunodeficiency syndrome
salivary gland disease associated with acquired immunodeficiency syndrome
salmonella infection associated with acquired immunodeficiency syndrome
skin disorder associated with acquired immunodeficiency syndrome
dermatomycosis associated with acquired immunodeficiency syndrome
hyperhidrosis associated with acquired immunodeficiency syndrome
skin rash associated with acquired immunodeficiency syndrome
strongyloidiasis associated with acquired immunodeficiency syndrome
subacute endocarditis associated with acquired immunodeficiency syndrome
subacute myocarditis associated with acquired immunodeficiency syndrome
thrombocytopenia associated with acquired immunodeficiency syndrome
family history of acquired immune deficiency syndrome
cholangitis associated with acquired immunodeficiency syndrome
acquired immune deficiency syndrome complicating childbirth
kaposi sarcoma not associated with acquired immunodeficiency syndrome
assessment using assessment of intelligibility of dysarthric speech
assessment of intelligibility of dysarthric speech
assessment of intelligibility of dysarthric speech score
infection caused by coccidia co-occurrent with acquired immunodeficiency syndrome
infection caused by toxoplasma gondii co-occurrent with acquired immunodeficiency syndrome
infection caused by isospora co-occurrent with acquired immunodeficiency syndrome
assessment using acquired immunodeficiency syndrome risk behavior knowledge test
acquired immunodeficiency syndrome risk behavior knowledge test total score
human immunodeficiency virus receptor
human immunodeficiency virus type 1 dot blot immunobinding assay
human immunodeficiency virus
human immunodeficiency virus type 1 passive hemagglutination assay
measurement of human immunodeficiency virus 2 antibody
measurement of human immunodeficiency virus 1 antibody
human immunodeficiency virus antigen test
human immunodeficiency virus-2 antigen assay
human immunodeficiency virus type 2
human immunodeficiency virus type 1 western blot assay
human immunodeficiency virus infection with infectious mononucleosis-like syndrome
human immunodeficiency virus type 1 radioimmunoprecipitation assay
human immunodeficiency virus type 1 antibody confirmatory test
congenital human immunodeficiency virus infection
human immunodeficiency virus type 2 confirmatory assay
human immunodeficiency virus 1 enzyme linked immunosorbent assay
human immunodeficiency virus-1 indirect immunofluorescence assay
human immunodeficiency virus-1 rapid latex agglutination assay
human immunodeficiency virus infection
human immunodeficiency virus infection with acute lymphadenitis
human immunodeficiency virus type i
asymptomatic human immunodeficiency virus infection
asymptomatic human immunodeficiency virus infection in pregnancy
antigen of human immunodeficiency virus protein 24
human immunodeficiency virus centers for disease control and prevention category a1
human immunodeficiency virus centers for disease control and prevention category a2
human immunodeficiency virus centers for disease control and prevention category a3

human immunodeficiency virus centers for disease control and prevention category b1
human immunodeficiency virus centers for disease control and prevention category b2
human immunodeficiency virus centers for disease control and prevention category b3

human immunodeficiency virus centers for disease control and prevention category c1

human immunodeficiency virus centers for disease control and prevention category c2

human immunodeficiency virus centers for disease control and prevention category c3

human immunodeficiency virus world health organization class i
human immunodeficiency virus world health organization class ii
human immunodeficiency virus world health organization class iii
human immunodeficiency virus world health organization class iv

human immunodeficiency virus p24 antigen test
antigen of human immunodeficiency virus 1 glycoprotein 120
antigen of human immunodeficiency virus 1 glycoprotein 160
antigen of human immunodeficiency virus 2 protein 41
acute human immunodeficiency virus infection
antigen of human immunodeficiency virus 1
human immunodeficiency virus deoxyribonucleic acid assay
human immunodeficiency virus 1 deoxyribonucleic acid assay
human immunodeficiency virus 1 ribonucleic acid assay
human immunodeficiency virus culture
human immunodeficiency virus type 1 identification
human immunodeficiency virus 1 antibody band pattern determination
measurement of human immunodeficiency virus 1 glycoprotein 105 antibody
measurement of human immunodeficiency virus 1 glycoprotein 120 antibody
measurement of human immunodeficiency virus 1 glycoprotein 120 and glycoprotein 160 antibody
measurement of human immunodeficiency virus 1 glycoprotein 160 antibody
measurement of human immunodeficiency virus 1 glycoprotein 34 antibody
measurement of human immunodeficiency virus 1 glycoprotein 41 antibody
measurement of human immunodeficiency virus 1 glycoprotein 41 and glycoprotein 43 antibody
measurement of human immunodeficiency virus 1 protein 15 antibody
measurement of human immunodeficiency virus 1 protein 15 antibody and protein 18 antibody
measurement of human immunodeficiency virus 1 protein 17 antibody
measurement of human immunodeficiency virus 1 protein 18 antibody
measurement of human immunodeficiency virus 1 protein 23 antibody
measurement of human immunodeficiency virus 1 protein 24 antibody
measurement of human immunodeficiency virus 1 protein 26 antibody
measurement of human immunodeficiency virus 1 protein 28 antibody
measurement of human immunodeficiency virus 1 protein 31 antibody
measurement of human immunodeficiency virus 1 protein 32 antibody
measurement of human immunodeficiency virus 1 protein 51 antibody
measurement of human immunodeficiency virus 1 protein 53 antibody
measurement of human immunodeficiency virus 1 protein 55 antibody
measurement of human immunodeficiency virus 1 protein 58 antibody
measurement of human immunodeficiency virus 1 protein 64 antibody
measurement of human immunodeficiency virus 1 protein 65 antibody
measurement of human immunodeficiency virus 1 protein 66 antibody
measurement of human immunodeficiency virus 1 protein 68 antibody
measurement of human immunodeficiency virus 2 glycoprotein 105 antibody
measurement of human immunodeficiency virus 2 glycoprotein 120 antibody
measurement of human immunodeficiency virus 2 glycoprotein 125 antibody
measurement of human immunodeficiency virus 2 protein 15 antibody
measurement of human immunodeficiency virus 2 glycoprotein 34 antibody
measurement of human immunodeficiency virus 2 glycoprotein 36 antibody
measurement of human immunodeficiency virus 2 glycoprotein 80 antibody
measurement of human immunodeficiency virus 2 protein 26 antibody
measurement of human immunodeficiency virus 2 protein 31 antibody
measurement of human immunodeficiency virus 2 protein 41 antibody
measurement of human immunodeficiency virus 2 protein 53 antibody
measurement of human immunodeficiency virus 2 protein 55 antibody
measurement of human immunodeficiency virus 2 protein 56 antibody
measurement of human immunodeficiency virus 2 protein 58 antibody
measurement of human immunodeficiency virus 2 protein 68 antibody
human immunodeficiency virus 1 antigen assay
human immunodeficiency virus 1 p24 antigen assay
antigen of human immunodeficiency virus 1 protein 24
human immunodeficiency virus, type ii glycoprotein 125 antibody
human immunodeficiency virus, type ii glycoprotein 36 antibody
human immunodeficiency virus, type i protein 23 antibody
human immunodeficiency virus, type i protein 32 antibody
human immunodeficiency virus, type i protein 28 antibody
human immunodeficiency virus, type i protein 65 antibody
human immunodeficiency virus, type ii protein 68 antibody
human immunodeficiency virus, type ii protein 56 antibody
human immunodeficiency virus, type ii protein 26 antibody
human immunodeficiency virus, type ii glycoprotein 80 antibody
human immunodeficiency virus, type i glycoprotein 105 antibody
human immunodeficiency virus, type i protein 58 antibody
human immunodeficiency virus, type i protein 51 antibody
human immunodeficiency virus, type i protein 66 antibody
human immunodeficiency virus, type i protein 55 antibody
human immunodeficiency virus, type i protein 31 antibody
human immunodeficiency virus, type ii protein 24 antibody
human immunodeficiency virus, type i protein 17 antibody
human immunodeficiency virus, type i glycoprotein 41 antibody
human immunodeficiency virus, type i glycoprotein 120 antibody
human immunodeficiency virus, type i glycoprotein 160 antibody
human immunodeficiency virus, type i protein 64 antibody
human immunodeficiency virus, type ii protein 41 antibody
human immunodeficiency virus, type i protein 53 antibody
human immunodeficiency virus, type i protein 18 antibody
human immunodeficiency virus, type i glycoprotein 34 antibody
human immunodeficiency virus, type i protein 26 antibody
human immunodeficiency virus, type i protein 15 antibody
fear of contracting human immunodeficiency virus infection
human immunodeficiency virus antibody test
human immunodeficiency virus negative
human immunodeficiency virus positive
human immunodeficiency virus screening
patient advised about the risks of human immunodeficiency virus
human immunodeficiency virus infection constitutional disease
human immunodeficiency virus leukoencephalopathy
neuropathy caused by human immunodeficiency virus
human immunodeficiency virus enteropathy
human immunodeficiency virus myopathy
human immunodeficiency virus infection classification systems
human immunodeficiency virus antibody
human immunodeficiency virus risk lifestyle
congenital human immunodeficiency virus positive status syndrome
human immunodeficiency virus status
human immunodeficiency virus-related sclerosing cholangitis
human immunodeficiency virus counseling
human immunodeficiency virus prevention education
human immunodeficiency virus infection with aseptic meningitis
human immunodeficiency virus viral load
measurement of both human immunodeficiency virus 1 antibody and human immunodeficiency virus 2 antibody
finding of human immunodeficiency virus status
human immunodeficiency virus antibody titer measurement
human immunodeficiency virus centers for disease control and prevention category
human immunodeficiency virus world health organization class
human immunodeficiency virus centers for disease control and prevention category finding
human immunodeficiency virus world health organization class finding
antenatal screening for human immunodeficiency virus
human immunodeficiency virus-1 nucleic acid assay
polymerase chain reaction test for human immunodeficiency virus type 1
oral hairy leukoplakia associated with human immunodeficiency virus disease
human immunodeficiency virus encephalitis
pediatric human immunodeficiency virus infection
human immunodeficiency virus enzyme-linked immunosorbent assay test negative
human immunodeficiency virus enzyme-linked immunosorbent assay test positive
antenatal human immunodeficiency virus blood screening test status
antenatal human immunodeficiency virus blood screening test sent
antenatal human immunodeficiency virus blood screening test requested
rapid human immunodeficiency virus type 1 antibody test
human immunodeficiency virus type 1 antibody
leukoplakia of tongue associated with human immunodeficiency virus disease
hairy leukoplakia of tongue associated with human immunodeficiency virus disease
retinopathy associated with acquired immunodeficiency syndrome
cachexia associated with acquired immunodeficiency syndrome
family history of human immunodeficiency virus infection
copies of human immunodeficiency virus ribonucleic acid above reference range
human immunodeficiency virus, type ii antibody
determination of susceptibility of human immunodeficiency virus 1 to panel of antiretroviral drugs using genotypic technique
determination of susceptibility of human immunodeficiency virus 1 to panel of antiretroviral drugs using phenotypic technique
determination of coreceptor tropism of human immunodeficiency virus 1
pulmonary arterial hypertension associated with human immunodeficiency virus infection
human immunodeficiency virus carrier
human immunodeficiency virus in mother complicating childbirth
symptomatic human immunodeficiency virus i infection
human immunodeficiency virus
human immunodeficiency virus
human immunodeficiency virus
human immunodeficiency virus
human immunodeficiency virus ii infection
ribonucleic acid of human immunodeficiency virus 2
deoxyribonucleic acid of human immunodeficiency virus 2
human immunodeficiency virus 1 and virus 2 antibodies and human immunodeficiency virus 1 p24 antigen combination immunoassay
immunoglobulin g antibody to human immunodeficiency virus type 1
immunoglobulin g antibody to human immunodeficiency virus type 2
proviral deoxyribonucleic acid of human immunodeficiency virus 1
proviral deoxyribonucleic acid of human immunodeficiency virus 2
human immunodeficiency virus 1 antibody indeterminate
human immunodeficiency virus 2 antibody indeterminate
human immunodeficiency virus 2 antibody positive and human immunodeficiency virus 1 antibody cross-reactivity
human immunodeficiency virus screening declined
invasive carcinoma of uterine cervix co-occurrent with human immunodeficiency virus infection
extrapulmonary tuberculosis co-occurrent with human immunodeficiency virus infection
world health organization 2007 human immunodeficiency virus infection clinical stage 1
world health organization 2007 human immunodeficiency virus infection clinical stage 2
world health organization 2007 human immunodeficiency virus infection clinical stage 3
world health organization 2007 human immunodeficiency virus infection clinical stage 4
human immunodeficiency virus fusion inhibitor
human immunodeficiency virus world health organization 2007 stage 1 co-occurrent with malaria
human immunodeficiency virus world health organization 2007 stage 2 co-occurrent with malaria
human immunodeficiency virus world health organization 2007 stage 3 co-occurrent with malaria
human immunodeficiency virus world health organization 2007 stage 4 co-occurrent with malaria
human immunodeficiency virus world health organization 2007 stage 4 co-occurrent with tuberculosis
human immunodeficiency virus world health organization 2007 stage 1 co-occurrent with tuberculosis
human immunodeficiency virus world health organization 2007 stage 2 co-occurrent with tuberculosis
human immunodeficiency virus world health organization 2007 stage 3 co-occurrent with tuberculosis
human immunodeficiency virus entry inhibitor
symptomatic human immunodeficiency virus infection
ribonucleic acid of human immunodeficiency virus 1
deoxyribonucleic acid of human immunodeficiency virus
deoxyribonucleic acid of human immunodeficiency virus 1
human immunodeficiency virus social work service
human immunodeficiency virus nurse practitioner service
human immunodeficiency virus nursing specialty
human immunodeficiency virus social work specialty
bacterial infection due to human immunodeficiency virus infection
encephalitis caused by human immunodeficiency virus type 1
esophagitis due to human immunodeficiency virus disease
transmitted by
mycobacterium, non-tuberculosis
notification of tuberculosis
tuberculosis screening
examination for suspected tuberculosis
tuberculosis chemotherapy
acute tuberculous pericarditis
genital tuberculosis
tuberculosis
tuberculosis of meninges
tuberculosis of urinary organs
entire terminal bronchiole
tuberculosis of bladder
mycobacterium tuberculosis hominis
tuberculosis of kidney
tuberculosis of genitourinary system
tuberculosis of ureter
pulmonary tuberculosis
atypical mycobacterial infection
tuberculosis, extrapulmonary
tuberculosis in mother complicating childbirth
tuberculous laryngitis
tuberculous peritonitis
primary tuberculosis
tuberculous salpingitis
tuberculous erythema nodosum
tuberculous cervicitis
extrapulmonary tuberculosis co-occurrent with human immunodeficiency virus infection
screening for cancer
laparotomy for staging of ovarian cancer
fear of getting cancer
prescription for alteration of hormonal balance for cancer
cancer hospital
pleurodesis with cancer chemotherapy substance
no microscopic confirmation - clinically metastatic tumor

immunotherapy for cancer
no microscopic confirmation - clinically malignant tumor

hyperthermia treatment of cancer
malignant neoplasm, primary
intra-arterial infusion of antineoplastic agent
cancer antigen 125
cancer antigen 19-5
cancer antigen 19-9
cancer antigen 242
cancer antigen 27-29
cancer antigen 50
cancer antigen 549
cancer antigen 72-4
cancer antigen 15-3
gleason grading system for prostatic cancer
walter reed staging of prostatic cancer
cancer antigen dm /70k
howel-evans' syndrome
cancer procoagulant
suspected breast cancer
suspected lung cancer
malignant tumor of nasopharynx
malignant tumor of undescended testis
malignant tumor of ectopic testis
malignant tumor of body of penis
secondary malignant neoplasm of cervix uteri
cancer education
united kingdom children's cancer study group central nervous system tumor staging system
american urological association staging system for prostate cancer
squamous cell carcinoma of bronchus
small cell carcinoma of lung
non-small cell lung cancer
malignant neoplasm of breast
cancer en cuirasse
familial cancer of breast
malignant tumor of skin of penis
malignant neoplasm of unknown origin
malignant tumor of salivary gland
malignant tumor of exocrine pancreas
cancer staging
history of malignant neoplasm
family history: stomach cancer
family history: bowel cancer
family history: bronchus cancer
family history of cancer
early gastric cancer
late gastric cancer
cancer attitude inventory
mental adjustment to cancer scale
family history of cancer of colon
hereditary nonpolyposis colon cancer
suspected cervical cancer
suspected endometrial cancer
suspected prostate cancer
suspected bladder cancer
suspected kidney cancer
suspected urothelial cancer
suspected testicular cancer
suspected upper gastrointestinal cancer
suspected lower gastrointestinal cancer
suspected skin cancer
suspected head and neck cancer
secondary malignant neoplastic disease
t3
malignant neoplasm of liver
secondary malignant neoplasm of liver
secondary malignant neoplasm of ovary
secondary malignant neoplasm of skin
secondary malignant neoplasm of vertebral column
secondary malignant neoplasm of vulva
cancer protocol observable
cancer dataset administrative items
basis of cancer diagnosis
cancer diagnosis based on death certificate
cancer diagnosis based on clinical evidence
cancer diagnosis based on investigations, without a tissue diagnosis
cancer diagnosis based on specific tumor markers
cancer diagnosis based on cytological evidence
cancer diagnosis based on metastatic histological evidence
cancer diagnosis based on primary site histological evidence
reason for no specific anti-cancer treatment
no anti-cancer treatment - poor performance status
no anti-cancer treatment - advanced stage cancer
patient died before anti-cancer treatment
no anti-cancer treatment - significant co-morbidity
no anti-cancer treatment available
no anti-cancer treatment - watchful waiting
cancer treatment related morbidity
malignant tumor of cecum
malignant tumor of esophagus
malignant neoplastic disease
malignant tumor of lip
malignant tumor of stomach
malignant tumor of rectum
malignant tumor of anal canal
malignant tumor of cervix
malignant tumor of adrenal gland
malignant neoplasm of ill-defined site
malignant tumor of lung
malignant tumor of vulva
malignant tumor of tongue
malignant tumor of parotid gland
malignant tumor of gum
malignant tumor of floor of mouth
malignant tumor of buccal mucosa
malignant tumor of palate
malignant tumor of oropharynx
malignant tumor of tonsil
malignant tumor of duodenum
malignant neoplasm of colon
malignant tumor of pancreas
malignant neoplasm of omentum
malignant tumor of larynx
malignant tumor of trachea
malignant tumor of pleura
malignant tumor of vertebral column
malignant tumor of ovary
malignant tumor of vagina
malignant tumor of foreskin
malignant tumor of glans penis
malignant tumor of scrotum
malignant tumor of ureter
malignant tumor of urethra
malignant tumor of thyroid gland
malignant tumor of parathyroid gland
malignant tumor of pituitary gland
malignant tumor of vocal cord
malignant tumor of peritoneum
malignant tumor of bronchus
malignant tumor of muscle
multiple malignancy
malignant tumor of oral cavity
malignant neoplasm of pharynx
malignant tumor of intestine
malignant tumor of large intestine
malignant tumor of penis
malignant tumor of kidney
malignant neoplasm of uterus
primary malignant neoplasm of bronchus
secondary malignant neoplasm of bone
secondary malignant neoplasm of brain
secondary malignant neoplasm of kidney
secondary malignant neoplasm of lung
secondary malignant neoplasm of lymph node
gleason grade finding for prostatic cancer
cancer registrar
cancer pagurus specific immunoglobulin e
cancer pagurus specific immunoglobulin e antibody measurement
cancer treatment started
cancer diagnosis discussed
cancer confirmed
no evidence of cancer found
cancer primary healthcare multidisciplinary team
cancer diagnosis discussed with partner in relationship
cancer diagnosis discussed with patient
cancer care plan discussed with patient
cancer care plan discussed with partner in relationship
pt3a


suspected central nervous system cancer
suspected urological cancer
suspected gynecological cancer
suspected children's cancer
multidisciplinary care conference for cancer care planning
monitoring of patient with cancer
no anti-cancer treatment due to unknown primary
cancer supportive care worker
phobic fear of skin cancer
suspected hematological malignancy
suspected malignancy
malignant tumor of prostate
malignant tumor of urinary bladder
risk control behavior: cancer
breast cancer type 1 susceptibility protein
breast cancer type 2 susceptibility protein
college of american pathologists cancer checklist; adrenal gland: resection
college of american pathologists cancer checklist; ampulla of vater: ampullectomy
college of american pathologists cancer checklist; ampulla of vater: pancreaticoduodenectomy
college of american pathologists cancer checklist; anus: excisional biopsy
college of american pathologists cancer checklist; anus: local excision

college of american pathologists cancer checklist; anus: resection
college of american pathologists cancer checklist; urinary bladder, ureter, renal pelvis: biopsy
college of american pathologists cancer checklist; urinary bladder: cystectomy, partial, total, or radical; anterior exenteration
college of american pathologists cancer checklist; renal pelvis: resection/nephroureterectomy, partial or complete
college of american pathologists cancer checklist; ureter: resection
college of american pathologists cancer checklist; bone marrow: blood film, aspirate, cell block, trephine biopsy, touch imprint
college of american pathologists cancer checklist; brain/spinal cord: biopsy/resection
college of american pathologists cancer checklist; breast: excision less than total mastectomy
college of american pathologists cancer checklist; colon and rectum: excisional biopsy

college of american pathologists cancer checklist; rectum: local excision

college of american pathologists cancer checklist; colon and rectum: resection
college of american pathologists cancer checklist; endometrium: biopsy
college of american pathologists cancer checklist; endometrium: hysterectomy, with or without other organs or tissues
college of american pathologists cancer checklist; esophagus: biopsy
college of american pathologists cancer checklist; esophagus: resection
college of american pathologists cancer checklist; extrahepatic bile ducts: resection
college of american pathologists cancer checklist; uveal melanoma: resection
college of american pathologists cancer checklist; vulva: excisional biopsy/resection
college of american pathologists cancer checklist; vagina: biopsy
college of american pathologists cancer checklist; vagina: excisional biopsy, resection
college of american pathologists cancer checklist; uterine cervix: cone biopsy
college of american pathologists cancer checklist; uterine cervix: colpectomy, hysterectomy, pelvic exenteration
college of american pathologists cancer checklist; upper aerodigestive tract and minor salivary glands: incisional and excisional biopsy/resection
college of american pathologists cancer checklist; major salivary glands: resection
college of american pathologists cancer checklist; trophoblast: dilation and curettage/resection
college of american pathologists cancer checklist; thyroid: resection
college of american pathologists cancer checklist; thymoma and thymic carcinoma: biopsy
college of american pathologists cancer checklist; thymoma and thymic carcinoma: thymectomy, other procedure
college of american pathologists cancer checklist; pleura/pericardium: resection
college of american pathologists cancer checklist; pleura/pericardium: biopsy
college of american pathologists cancer checklist; testis: radical orchiectomy
college of american pathologists cancer checklist; testis: retroperitoneal lymphadenectomy
college of american pathologists cancer checklist; stomach: biopsy
college of american pathologists cancer checklist; stomach: resection
college of american pathologists cancer checklist; small intestine: polypectomy, segmental resection, pancreaticoduodenectomy, partial or complete, with or without partial gastrectomy

college of american pathologists cancer checklist; melanoma of the skin: excision; re-excision
college of american pathologists cancer checklist; fallopian tube: unilateral salpingectomy, salpingo-oophorectomy, or hysterectomy with salpingo-oophorectomy
college of american pathologists cancer checklist; gallbladder: resection/cholecystectomy
college of american pathologists cancer checklist; gastrointestinal lymphoma: resection
college of american pathologists cancer checklist; heart: resection
college of american pathologists cancer checklist; hodgkin lymphoma: biopsy/staging procedure
college of american pathologists cancer checklist; kidney: biopsy
college of american pathologists cancer checklist; kidney: nephrectomy, partial or radical
college of american pathologists cancer checklist; liver: resection
college of american pathologists cancer checklist; lung: biopsy
college of american pathologists cancer checklist; lung: resection
college of american pathologists cancer checklist; non-hodgkin lymphoma: biopsy, resection
college of american pathologists cancer checklist; ovary: oophorectomy, salpingo-oophorectomy, subtotal oophorectomy or removal of tumor in fragments, hysterectomy with salpingo-oophorectomy
college of american pathologists cancer checklist; pancreas
college of american pathologists cancer checklist; pancreas
college of american pathologists cancer checklist; peritoneum: resection
college of american pathologists cancer checklist; prostate gland: needle biopsy, transurethral prostatic resection, enucleation specimen
college of american pathologists cancer checklist; prostate gland: radical prostatectomy
college of american pathologists cancer checklist; retinoblastoma: enucleation, partial or complete exenteration
college of american pathologists cancer checklist; carcinoma of the skin: resection
college of american pathologists cancer checklist; rhabdomyosarcoma and related neoplasms: excision, local or wide; compartmentectomy; excision, radical; amputation; other
college of american pathologists cancer checklist; kidney: resection for wilms tumor
seen by breast cancer nurse
widespread metastatic malignant neoplastic disease
college of american pathologists cancer checklist; neuroblastoma: resection
college of american pathologists cancer checklist; primitive neuroectodermal tumor / ewing sarcoma: resection
cancer pagurus diagnostic allergen extract
family history of prostate cancer
cancer monitoring third letter
cancer monitoring second letter
cancer monitoring first letter
cancer monitoring invitation
cancer hospital treatment completed
cancer emotional and psychosocial support and education
cancer screening follow up
no evidence of recurrence of cancer
cancer short term health assessment
cancer rehabilitation and readaption
cancer pain and symptom management
carcinoma-associated retinopathy
malignant neoplasm of skin
cancer shared care medication card
cancer monitoring verbal invitation
cancer home care pack given
international federation of gynecology and obstetrics cervical cancer stage i
international federation of gynecology and obstetrics cervical cancer stage ib
international union against cancer
american joint committee on cancer
international union against cancer stage grouping
european organization for research and treatment of cancer - quality of life questionnaire
international federation of gynecology and obstetrics endometrial cancer stage ii
international federation of gynecology and obstetrics endometrial cancer stage iv
international federation of gynecology and obstetrics cervical cancer stage ia
international federation of gynecology and obstetrics endometrial cancer stage i a
international federation of gynecology and obstetrics endometrial cancer stage i
international federation of gynecology and obstetrics cervical cancer stage iii
international federation of gynecology and obstetrics cervical cancer stage ii
international federation of gynecology and obstetrics endometrial cancer stage i b
international federation of gynecology and obstetrics cervical cancer stage iv
international federation of gynecology and obstetrics endometrial cancer stage iii
international federation of gynecology and obstetrics cervical cancer stage ib occ
college of american pathologists cancer checklist; appendix: resection
college of american pathologists cancer checklist; prostate gland: needle biopsy
college of american pathologists cancer checklist; prostate gland: transurethral prostatic resection, enucleation specimen
college of american pathologists cancer checklist; bone: resection
college of american pathologists cancer checklist; bone: biopsy
college of american pathologists cancer checklist; soft tissue: resection
college of american pathologists cancer checklist; soft tissue: biopsy
primary malignant neoplasm of thyroid gland, metastatic to bone
primary malignant neoplasm of ovary, with widespread metastatic disease
primary malignant neoplasm of vulva, with widespread metastatic disease
hormone refractory prostate cancer
non-small cell lung cancer, negative for epidermal growth factor receptor expression
french federation of cancer centers sarcoma group grading system
national cancer institute histologic grading system
non-small cell lung cancer, positive for epidermal growth factor receptor expression
psychosocial counseling about cancer
family history of cancer of the esophagus
family history of breast cancer 1 gene mutation
family history of breast cancer 2 gene mutation
increased cancer antigen 125
family history of malignant neoplasm of liver
family history of malignant neoplasm of pancreas
family history of malignant neoplasm of lung
family history of malignant neoplasm of skin
knowledge level about cancer prevention and early detection
knowledge level about cancer management
measurement of cancer antigen 72-4
american joint commission on cancer, cancer staging manual, 6th edition neoplasm staging system
american joint commission on cancer, cancer staging manual, 7th edition neoplasm staging system
edition of american joint commission on cancer, cancer staging manual used for tnm staging
cancer antigen 27-29 above reference range
residual cancer burden index
breast cancer genetic marker of susceptibility negative
measurement of cancer antigen 27-29
residual cancer burden class
residual cancer burden score
residual cancer burden index
breast cancer genetic marker of susceptibility positive
malignant neoplasm detection during interval between recommended screening examinations
brca1 mutation carrier detection test
brca1 gene mutation negative
brca1 gene mutation positive
brca2 gene mutation positive
brca2 mutation carrier detection test
brca2 gene mutation negative
malignant neoplasm of urinary organ
malignant neoplasm of respiratory system
malignant neoplasm of cerebellum
malignant neoplasm of carotid body
malignant neoplasm of cerebellopontine angle
malignant neoplasm of pelvic peritoneum
transglottic malignant neoplasm of larynx
malignant neoplasm of visceral pleura
malignant neoplasm of skin of scrotum
malignant neoplasm of upper respiratory tract
malignant neoplasm of parietal pleura
malignant neoplasm of intraabdominal organ
malignant neoplasm of mandible
malignant neoplasm of soft tissue of orbit
malignant neoplasm of posterior mediastinum
nottingham histologic grading system
malignant neoplasm of lateral wall of oropharynx
malignant neoplasm of alveolus of maxilla
malignant neoplasm of anterior mediastinum
malignant neoplasm of parametrium
malignant neoplasm of digestive system
malignant neoplasm of anterior and lateral floor of mouth
malignant neoplasm of alveolus of mandible
malignant neoplasm of broad ligament of uterus
malignant neoplasm of alveolus dentalis
verrucous carcinoma of oral cavity
electro cancer therapy system
educated about screening for malignant neoplasm of prostate
family history of colorectal cancer
patient advised about prostate cancer screening
pt4: tumor involves any of the ipsilateral pleural surfaces plus additional sites as by american joint committee on cancer 6th edition definition

pt3: tumor involves any of the ipsilateral pleural surfaces plus additional sites as by american joint committee on cancer 6th edition definition

pt4: tumor of lung as per american joint committee on cancer 6th edition definition

pt4: extraocular tumor extension which includes sites as per american joint committee on cancer 6th edition definition

pt2: tumor of lung as per american joint committee on cancer 6th edition definition

pn3b: tumor of breast with metastasis as per american joint committee on cancer 6th edition definition

hereditary cancer-predisposing syndrome
cancer antigen 19-9 measurement
cancer antigen 15-3 measurement
alternating electric field antimitotic cancer treatment system
alternating electric field antimitotic cancer treatment system transducer array
alternating electric field antimitotic cancer treatment system generator
screening for malignant neoplasm of vagina done
history of malignant neoplasm of vulva
malignant neoplastic disease in mother complicating childbirth
screening for malignant neoplasm of vagina
sampling of vagina for papanicolaou smear after hysterectomy for malignant disease done
anemia in malignant neoplastic disease
non-small cell lung cancer without mutation in epidermal growth factor receptor
non-small cell lung cancer with mutation in epidermal growth factor receptor
primary malignant neoplasm of endocervix
primary malignant neoplasm of endometrium
secondary malignant neoplasm of vagina
carcinoma of ovary, stage 3
history of malignant neoplasm of ovary
carcinoma of ovary, stage 1
carcinoma of ovary, stage 2
carcinoma of ovary, stage 4
primary malignant neoplasm of clitoris
history of malignant neoplasm of uterine adnexa
history of malignant neoplasm of cervix
history of malignant neoplasm of uterine body
history of malignant neoplasm of vagina
undifferentiated carcinoma of ovary
at risk of breast cancer
triple negative malignant neoplasm of breast
international federation of gynecology and obstetrics cervical cancer
international federation of gynecology and obstetrics endometrial cancer stage iiib
international federation of gynecology and obstetrics cervical cancer
international federation of gynecology and obstetrics cervical cancer
international federation of gynecology and obstetrics cervical cancer
international federation of gynecology and obstetrics cervical cancer
international federation of gynecology and obstetrics cervical cancer
international federation of gynecology and obstetrics endometrial cancer
international federation of gynecology and obstetrics cervical cancer
international federation of gynecology and obstetrics cervical cancer
international federation of gynecology and obstetrics cervical cancer
international federation of gynecology and obstetrics endometrial cancer stage iiic1
international federation of gynecology and obstetrics cervical cancer
international federation of gynecology and obstetrics cervical cancer
international federation of gynecology and obstetrics endometrial cancer stage iiic2
international federation of gynecology and obstetrics endometrial cancer
international federation of gynecology and obstetrics endometrial cancer
malignant neoplasm of exocervix
history of non-small cell malignant neoplasm of lung
family history of malignant neoplasm of male breast
family history of malignant neoplasm of cervix uteri
family history of malignant neoplasm of ileum
family history of malignant neoplasm of vagina
family history of malignant neoplasm of brain
history of malignant neoplasm of esophagus
history of malignant neoplasm of neck
history of malignant neoplasm of bone
secondary malignant neoplasm of central nervous system
secondary malignant neoplasm of cerebral meninges
secondary malignant neoplasm of bone marrow
family history of malignant neoplasm of uterus
family history of malignant neoplasm of bone
secondary malignant neoplasm of bladder
history of malignant neoplasm of endocrine gland
history of malignant neoplasm of tongue
secondary malignant neoplasm of adrenal gland
history of malignant neoplasm of spinal cord
history of malignant neoplasm of nervous system
carcinoma in situ of ileum
secondary malignant neoplasm of intercostal lymph nodes
secondary malignant neoplasm of lymph nodes of face
overlapping malignant neoplasm of small intestine
carcinoma in situ of tongue
secondary malignant neoplasm of intrapelvic lymph nodes
secondary malignant neoplasm of tracheobronchial lymph nodes
carcinoma in situ of eye
carcinoma in situ of vulva
squamous cell carcinoma of penis
squamous cell carcinoma of tip of nose
squamous cell carcinoma of forehead
malignant neoplasm of cerebral meninges
carcinoma in situ of small intestine
carcinoma of uterine cervix, invasive
secondary malignant neoplasm of intra-abdominal organs
malignant mesothelioma of peritoneum
secondary malignant neoplasm of chest wall
carcinoma of colon, stage i
malignant neoplasm of female breast
carcinoma in situ of prostate
secondary malignant neoplasm of prostate
malignant tumor of spinal cord, intramedullary
secondary malignant neoplasm of left ovary
secondary malignant neoplasm of thyroid gland
secondary malignant neoplasm of male genital organ
malignant mixed tumor of salivary gland
secondary malignant neoplasm of peritoneum
squamous cell carcinoma of scalp
squamous cell carcinoma of nasolabial fold
overlapping malignant neoplasm of eye and adnexa, primary
secondary malignant neoplasm of mediastinum
secondary malignant neoplasm of lymph nodes of upper limb
secondary malignant neoplasm of duodenum
overlapping malignant neoplasm of penis
overlapping malignant neoplasm of stomach
secondary malignant neoplasm of spleen
carcinoma in situ of common bile duct
squamous cell carcinoma of back
carcinoma in situ of skin
carcinoma in situ of rectum
malignant tumor of spinal cord, extramedullary
secondary malignant neoplasm of choroid
carcinoma in situ of gum
secondary malignant neoplasm of uterus
carcinoma in situ of mouth
overlapping malignant neoplasm of floor of mouth
secondary malignant neoplasm of inguinal lymph nodes
squamous cell carcinoma of temple
carcinoma in situ of pylorus
overlapping malignant neoplasm of brain
basal cell carcinoma of auricle of ear
secondary malignant neoplasm of rectosigmoid junction
secondary malignant neoplasm of tibial lymph nodes
malignant tumor of extrahepatic bile duct
carcinoma in situ of duodenum
carcinoma in situ of thyroid gland
secondary malignant neoplasm of hypogastric lymph nodes
secondary malignant neoplasm of female genital organ
malignant tumor of pineal gland
secondary malignant neoplasm of lymph nodes of lower limb
carcinoma in situ of oropharynx
carcinoma in situ of colon
secondary malignant neoplasm of lymph nodes of neck
carcinoma in situ of hypopharynx
squamous cell carcinoma of larynx
mesothelioma

stool dna-based colorectal cancer screening positive
overlapping malignant neoplasm of colon
carcinoma in situ of spleen
carcinoma in situ of cystic duct
secondary malignant neoplasm of intrathoracic lymph nodes
carcinoma in situ of bladder
carcinoma in situ
carcinoma in situ of penis
secondary malignant neoplasm of lymph nodes of head
carcinoma of urinary bladder, superficial
secondary malignant neoplasm of mesenteric lymph nodes
secondary malignant neoplasm of spinal meninges
carcinoma in situ of esophagus
metastasis from malignant tumor of prostate
secondary malignant neoplasm of esophagus
carcinoma in situ of lung
secondary malignant neoplasm of small intestine
secondary malignant neoplasm of respiratory tract
carcinoma in situ of pharynx
history of malignant neoplasm of penis
carcinoma in situ of vagina
carcinoma in situ of anal canal
secondary malignant neoplasm of iliac lymph nodes
malignant neoplasm of peripheral nerve of thorax
secondary malignant neoplasm of omentum
secondary malignant neoplasm of popliteal lymph nodes
secondary malignant neoplasm of pituitary gland
secondary malignant neoplasm of soft tissues of pelvis
secondary malignant neoplasm of lymph nodes of multiple sites
secondary malignant neoplasm of heart
secondary malignant neoplasm of pancreas
carcinoma in situ of jejunum
secondary malignant neoplasm of trachea
overlapping malignant neoplasm of major salivary gland
secondary malignant neoplasm of gallbladder
carcinoma of urinary bladder, invasive
secondary malignant neoplasm of pleura
squamous cell carcinoma of pharynx
secondary malignant neoplasm of urinary system
carcinoma in situ of larynx
malignant neoplasm of intrahepatic gall duct
carcinoma in situ of uterus
overlapping malignant neoplasm of palate
secondary malignant neoplasm of large intestine
secondary malignant neoplasm of retroperitoneal lymph nodes
squamous cell carcinoma of bridge of nose
squamous cell carcinoma in situ of skin
carcinoma in situ of urinary system
carcinoma in situ of gastrointestinal tract
secondary malignant neoplasm of stomach
secondary malignant neoplasm of nervous system
secondary malignant neoplasm of rectum
carcinoma in situ of pancreas
secondary malignant neoplasm of right ovary
overlapping malignant neoplasm of pancreas
malignant melanoma of anus
carcinoma in situ of salivary gland duct
carcinoma in situ of endocrine gland
malignant melanoma of rectum
secondary malignant neoplasm of pararectal lymph nodes
secondary malignant neoplasm of intestinal lymph nodes
malignant tumor of peripheral nerve
carcinoma of colon, stage iii
carcinoma of colon, stage ii
paget's disease of vulva
carcinoma of prostate
carcinoma of the rectosigmoid junction
secondary malignant neoplasm of obturator lymph nodes
basal cell carcinoma of chest wall
carcinoma of nasal meatus
malignant neoplasm of anorectum
hurthle cell carcinoma of thyroid
basal cell carcinoma of back
mucoepidermoid carcinoma of parotid gland
adenoid cystic carcinoma of submandibular gland
squamous cell carcinoma of skin of neck
metastasis to peripheral nerve
carcinoma of colon, stage iv
carcinoma of tip of nose
squamous cell carcinoma of oropharynx
metastasis to digestive organs
mucoepidermoid carcinoma of submandibular gland
family history of malignant neoplasm of trachea
basal cell carcinoma of scalp
basal cell carcinoma of upper extremity
carcinoma in situ of skin of scalp
carcinoma in situ of skin of eyelid
basal cell carcinoma of hand
history of cancer of unknown primary site
history of cancer metastatic to liver
history of cancer of gall bladder
basal cell carcinoma of truncal skin
history of cancer of ampulla of duodenum
history of cancer metastatic to lung
carcinoma in situ of skin of trunk
history of cancer of floor of mouth
carcinoma in situ of skin of upper limb
history of cancer metastatic to lymph nodes
carcinoma in situ of body of stomach
basal cell carcinoma of lower extremity
history of malignant neoplasm of eye
basal cell carcinoma of neck
history of cancer metastatic to skin
history of cancer metastatic to brain
family history of malignant neoplasm of genital structure
basal cell carcinoma of forehead
family history of malignant neoplasm of urinary bladder
basal cell carcinoma of upper eyelid
basal cell carcinoma of chin
history of cancer of urethra
history of cancer metastatic to bone
basal cell carcinoma of ear
carcinoma in situ of fundus of stomach
basal cell carcinoma of skin
carcinoma in situ of skin of face
basal cell carcinoma of skin of lip
carcinoma in situ of skin of neck
carcinoma in situ of body of pancreas
family history of malignant neoplasm of kidney
basal cell carcinoma of temple
basal cell carcinoma of nose
family history of malignant neoplasm of testis
carcinoma in situ of cardia of stomach
basal cell carcinoma of face
carcinoma in situ of skin of ear
carcinoma in situ of skin of lip
secondary malignant neoplasm of lumbosacral plexus
history of malignant neoplasm of rectosigmoid junction
cancer associated serum antigen
adenocarcinoma of stomach
cancer cervix screening - not attended
cancer cervix screening - wanted
cancer cervix screening - not reached
cancer cervix screening - up-to-date
cancer cervix screening status
family history of hereditary nonpolyposis colon cancer
cancer cervix screening - not needed
cancer cervix screen-no result yet
cancer cervix screening and fee claim
cancer cervix - screening done
screening for malignant neoplasm of breast
secondary malignant neoplasm of right lung
secondary malignant neoplasm of left lung
screening for malignant neoplasm of colon
screening for malignant neoplasm of skin
family history of breast cancer gene mutation in first degree relative
secondary malignant neoplasm of intra-abdominal lymph nodes
squamous cell carcinoma of skin of ear
squamous cell carcinoma of skin of lower extremity
squamous cell carcinoma of skin of face
screening for malignant neoplasm of cervix not wanted
active surveillance of prostate cancer
primary malignant neoplasm of prostate metastatic to bone
squamous cell carcinoma of vagina
primary malignant neoplasm of appendix
malignant tumor of sigmoid colon
primary malignant neoplasm of lung
malignant tumor of splenic flexure
malignant tumor of hepatic flexure
malignant tumor of transverse colon
malignant tumor of rectosigmoid junction
malignant tumor of ascending colon
malignant tumor of descending colon
familial malignant neoplasm of prostate
cervical cancer screening not done
colorectal cancer screening not done
carcinoma of salivary gland type of breast
fatigue associated with malignant neoplastic disease
hereditary diffuse carcinoma of stomach
claus model lifetime breast cancer risk assessment
breast cancer risk assessment tool
hereditary breast and ovarian cancer syndrome
monitoring following treatment for cancer
cancer care review
prostate cancer care review
prostate cancer care review done
prostate cancer screening declined
breast cancer screening declined
cervical cancer papanicolaou smear screening declined
colon cancer screening declined
hormone sensitive prostate cancer
obstructive nephropathy due to carcinoma of prostate
obstructive nephropathy due to bladder cancer
reactive oxygen species 1 positive non-small cell lung cancer
occupational cancer of skin
fear of having cancer of digestive system
fear of cancer of respiratory system
fear of cancer of endocrine system
fear of musculoskeletal cancer
fear of hematological cancer
squamous non-small cell lung cancer
family history of malignant neoplasm of ovary in first degree relative
genetic susceptibility to cancer
hereditary non-polyposis colon cancer gene mutation positive
family history of genetic mutation for hereditary nonpolyposis colon cancer
lung cancer screening
lung cancer screening declined
carrier of high risk cancer mutation gene
carrier of heritable cancer
cancer antigen 19-9 above reference range
fear of genital cancer
family history of malignant hematopoietic neoplasm
fear of breast cancer
family history of malignant neoplasm of ovary in second degree relative
high risk for cervical cancer
family history of nonleukemic lymphatic malignancy
family history of malignant neoplasm of colon over age 50
family history of heritable malignancy
family history of malignant neoplasm of breast at under age 50 in second degree relative
microsatellite instability-high solid malignant tumor
chronic pain due to malignant neoplastic disease
family history of breast cancer gene brca mutation
cancer care plan
screening for malignant neoplasm of cervix declined
microsatellite instability-high colorectal cancer
chronic pain following surgical procedure for cancer
suspected vulva cancer
suspected ovarian cancer
suspected bowel cancer
inherited cancer-predisposing syndrome due to biallelic brca2 mutation
family history of malignant neoplasm of breast at under age 50 in second degree female relative
family history of malignant neoplasm of breast
germline brca-mutated human epidermal growth factor receptor 2 negative metastatic carcinoma of breast
hereditary site-specific ovarian cancer syndrome
gastric adenocarcinoma and proximal polyposis of stomach
high grade astrocytoma of brain
low grade astrocytoma of brain
grade 2 astrocytoma of brain
primary differentiated carcinoma of thyroid gland
oligodontia and cancer predisposition syndrome
secondary malignant neoplasm of colon and/or rectum
primary malignant neoplasm of vulva
malignant neoplasm of colon and/or rectum
familial cutaneous telangiectasia and oropharyngeal cancer predisposition syndrome
chronic pain after cancer treatment
locally advanced breast cancer
anaplastic lymphoma kinase fusion oncogene negative non-small cell lung cancer
reactive oxygen species 1 negative non-small cell lung cancer
anaplastic lymphoma kinase fusion oncogene positive non-small cell lung cancer
primary malignant neoplasm of breast with axillary lymph node invasion
at increased risk of malignant neoplasm of breast
at risk of hereditary cancer-predisposing syndrome
functional assessment of cancer therapy - brain
ulcer due to cancer
severe manic bipolar i disorder without psychotic features
chronic bipolar ii disorder, most recent episode major depressive
bipolar i disorder, single manic episode with postpartum onset
bipolar i disorder, single manic episode, in full remission
severe bipolar disorder with psychotic features
bipolar disorder in partial remission
bipolar i disorder, single manic episode
severe mixed bipolar i disorder with psychotic features, mood-incongruent
severe mixed bipolar i disorder with psychotic features
severe bipolar ii disorder, most recent episode major depressive, in full remission
mild bipolar disorder
severe bipolar i disorder, single manic episode with psychotic features, mood-congruent
bipolar disorder
severe bipolar i disorder, single manic episode without psychotic features
bipolar ii disorder, most recent episode major depressive
mixed bipolar i disorder
bipolar i disorder, most recent episode manic with catatonic features
severe bipolar ii disorder, most recent episode major depressive with psychotic features, mood-congruent
severe bipolar ii disorder, most recent episode major depressive with psychotic features, mood-incongruent
bipolar i disorder, most recent episode depressed with catatonic features
depressed bipolar i disorder in full remission
bipolar ii disorder, most recent episode major depressive with catatonic features
severe depressed bipolar i disorder with psychotic features, mood-incongruent
severe bipolar disorder with psychotic features, mood-incongruent
severe manic bipolar i disorder with psychotic features
moderate bipolar i disorder, single manic episode
bipolar i disorder, most recent episode depressed with atypical features
severe bipolar ii disorder, most recent episode major depressive with psychotic features
bipolar ii disorder, most recent episode major depressive with postpartum onset
manic bipolar i disorder in full remission
bipolar i disorder, most recent episode hypomanic
severe manic bipolar i disorder with psychotic features, mood-incongruent
bipolar ii disorder, most recent episode major depressive with melancholic features
mixed bipolar i disorder in remission
severe bipolar ii disorder, most recent episode major depressive, in remission
moderate bipolar ii disorder, most recent episode major depressive
mixed bipolar i disorder in partial remission
schizoaffective disorder, bipolar type
moderate mixed bipolar i disorder
mild bipolar i disorder, single manic episode
severe bipolar i disorder, single manic episode with psychotic features
bipolar disorder in full remission
bipolar ii disorder, most recent episode major depressive with atypical features
mild mixed bipolar i disorder
manic bipolar i disorder in remission
severe mixed bipolar i disorder without psychotic features
bipolar ii disorder, most recent episode hypomanic
depressed bipolar i disorder
depressed bipolar i disorder in partial remission
chronic bipolar i disorder, most recent episode depressed
severe bipolar disorder without psychotic features
depressed bipolar i disorder in remission
severe depressed bipolar i disorder with psychotic features, mood-congruent
bipolar i disorder, most recent episode manic with postpartum onset
severe depressed bipolar i disorder with psychotic features
severe depressed bipolar i disorder without psychotic features
manic bipolar i disorder in partial remission
severe mixed bipolar i disorder with psychotic features, mood-congruent
bipolar i disorder, most recent episode mixed with postpartum onset
moderate depressed bipolar i disorder
severe bipolar ii disorder, most recent episode major depressive, in partial remission
manic bipolar i disorder
severe bipolar disorder with psychotic features, mood-congruent
mild bipolar ii disorder, most recent episode major depressive
mild manic bipolar i disorder
bipolar cells of retina
electrocoagulation
bipolar i disorder, most recent episode mixed with catatonic features
mild depressed bipolar i disorder
bipolar i disorder, single manic episode, in remission
bipolar i disorder, most recent episode depressed with melancholic features
bipolar i disorder, single manic episode, in partial remission
severe manic bipolar i disorder with psychotic features, mood-congruent
moderate bipolar disorder
severe bipolar ii disorder, most recent episode major depressive without psychotic features
moderate manic bipolar i disorder
bipolar ii disorder
bipolar disorder in remission
severe bipolar i disorder, single manic episode with psychotic features, mood-incongruent
bipolar i disorder, most recent episode depressed with postpartum onset
bipolar i disorder, single manic episode with catatonic features
mixed bipolar i disorder in full remission
family history: manic-depressive state
bipolar affective disorder, current episode manic
bipolar affective disorder, currently manic, mild
bipolar affective disorder, currently manic, moderate
bipolar affective disorder, currently manic, severe, with psychosis
bipolar affective disorder, currently manic, in full remission
bipolar affective disorder, current episode depression
bipolar affective disorder, currently depressed, mild
bipolar affective disorder, currently depressed, moderate
bipolar affective disorder, currently depressed, in full remission
mixed bipolar affective disorder
mixed bipolar affective disorder, mild
mixed bipolar affective disorder, moderate
mixed bipolar affective disorder, severe, with psychosis
mixed bipolar affective disorder, in full remission
bipolar affective disorder, current episode mixed
organic bipolar disorder
bipolar diathermy
bipolar
profile of mood states, bipolar
bipolar i disorder
severe bipolar i disorder
severe bipolar disorder
severe bipolar ii disorder
referral for bipolar disorder
severe mixed bipolar i disorder
severe depressed bipolar i disorder
rapid cycling bipolar i disorder
femoral head bipolar component
humeral head bipolar component
endotherapy electrosurgical coagulator/cutter, bipolar, refurbished
bipolar partial shoulder prosthesis
laparoscopic electrosurgical forceps, bipolar
endotherapy electrosurgical coagulator/cutter, bipolar, reusable
severe manic bipolar i disorder
planar-resection electrosurgical diathermy bipolar conducting unit
universal electrosurgical diathermy system bipolar electrode, reprocessed
universal electrosurgical diathermy system bipolar electrode, single-use
bipolar clinic
partial hip replacement with bipolar prosthesis
endoscopic electrosurgical electrode, bipolar, reprocessed
endoscopic electrosurgical electrode, bipolar, reusable
endoscopic electrosurgical electrode, bipolar, single-use
percutaneous electrosurgical probe, spinal-denervation, bipolar
laparoscopic electrosurgical forceps, bipolar, reprocessed
hysteroscopic bipolar electrosurgical excision of uterine fibroid
bipolar type ii disorder currently in full remission
bipolar type i disorder currently in full remission
robotic single-use bipolar electrosurgical instrument
robotic reusable bipolar electrosurgical instrument
psychosis and severe depression co-occurrent and due to bipolar affective disorder
bipolar disorder, most recent episode depression
bipolar disorder, most recent episode manic
bipolar affective disorder, most recent episode mixed
bipolar i disorder, most recent episode manic
bipolar i disorder, most recent episode depression
bipolar disorder caused by drug
rapid cycling bipolar ii disorder
mental disorder in childhood
maintenance drug therapy for mental disorder
initial drug therapy for mental disorder
psychoactive substance-induced organic mental disorder
opioid-induced organic mental disorder
insomnia disorder related to another mental disorder
mental disorder in infancy
mental disorder in adolescence
alcohol-induced organic mental disorder
nicotine-induced organic mental disorder
cocaine-induced organic mental disorder
hallucinogen-induced organic mental disorder
social problem not due to a mental disorder
inhalant-induced organic mental disorder
social maladjustment
mental disorder
cannabis-induced organic mental disorder
amphetamine-induced organic mental disorder
hypersomnia disorder related to another mental disorder
organic mental disorder of unknown etiology
mental disorder and/or culture bound syndrome
organic mental disorder
neurosis
chronic mental disorder
developmental mental disorder
family history of mental disorder
examination for suspected mental disorder
mental disorder during pregnancy - baby delivered
mental disorder in the puerperium - baby delivered
mental disorder during pregnancy - baby not yet delivered
mental disorder in the puerperium - baby delivered during previous episode of care
caffeine-induced organic mental disorder
arylcyclohexylamine-induced organic mental disorder
phencyclidine-related disorder
anxiolytic-induced organic mental disorder
hypnotic-induced organic mental disorder
specific nonpsychotic mental disorders following organic brain damage
mental disorders during pregnancy, childbirth and the puerperium
prune belly syndrome with pulmonic stenosis, mental retardation and deafness
hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities
pregnancy with mental disorders
profound intellectual disability
hyperphosphatasemia with intellectual disability
severe intellectual disability
moderate intellectual disability
concussion with mental confusion and/or disorientation without loss of consciousness
borderline intellectual disability
mild intellectual disability
hereditary insensitivity to pain with anhidrosis
intellectual disability, congenital heart disease, blepharophimosis, blepharoptosis and hypoplastic teeth
on examination - sub-mental lymphadenopathy
x-linked intellectual disability with marfanoid habitus
chronic organic mental disorder
transient organic mental disorder
mental disorder caused by drug
blepharophimosis-intellectual disability syndrome maat-kievit-brunner type
blepharophimosis-mental retardation syndrome, say-barber-biesecker-young-simpson type
x-linked intellectual disability-psychosis-macroorchidism syndrome
x-linked mental retardation syndrome, christianson type
x-linked intellectual disability snyder type
iris coloboma with ptosis, hypertelorism, and mental retardation
mental disorder in mother complicating pregnancy
mental disorder in mother complicating childbirth
short stature-characteristic facies-mental retardation-macrodontia-skeletal anomalies syndrome
phencyclidine induced mental problem
hypoplasia of corpus callosum and mental retardation with adducted thumbs and spasticity and hydrocephalus syndrome
brain anomaly, severe mental retardation, ectodermal dysplasia, skeletal deformity, ear anomaly, kidney dysplasia syndrome
intellectual disability, epileptic seizures, hypogonadism and hypogenitalism, microcephaly, obesity syndrome
macrocephaly, obesity, mental disability, ocular abnormality syndrome
fear of mental disorder
mental disorder caused by methamphetamine
blepharophimosis and mental retardation syndrome
mental retardation, adducted thumbs, shuffling gait, aphasia syndrome
post-traumatic stress disorder checklist for diagnostic and statistical manual of mental disorders - fifth edition total symptom severity score
post-traumatic stress disorder checklist for diagnostic and statistical manual of mental disorders - fifth edition
assessment using post-traumatic stress disorder checklist for diagnostic and statistical manual of mental disorders - fifth edition
excision of tumor of brain meninges
focal excision of brain tissue tumor
biopsy of brain tissue tumor
aspiration of cystic tumor of brain tissue
connection from cystic brain tumor to subcutaneous reservoir
aspiration of subcutaneous reservoir connecting to cystic brain tumor
destruction of brain tumor
injection of chemotherapeutic substance into tumor of brain tissue
tumor-node-metastasis
intracranial tumor
glial tumor of brain
astrocytoma of brain
ependymoma of brain
mixed glial tumor of brain
embryonal tumor of brain
brain tumor invasion status in retinoblastoma staging
location of brain tumor
tumor-like lesion of brain
suspected brain tumor
benign neoplasm of brain
pt4b: tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve, nasopharynx, or clivus

pt4b: tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve, nasopharynx, or clivus

germ cell tumor of the brain
excision of bone of cranium and excision of infratentorial neoplasm of brain
history of malignant neoplasm of brain
history of benign neoplasm of brain

abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
lamivudine
schedule h
guanosine
zidovudine
who model list of essential medicines
atc code j05
didanosine
bioretrosynthesis
allopurinol
fanconi syndrome
emtricitabine/tenofovir
ddi
bristol myers squibb
tenofovir disoproxil
reverse-transcriptase inhibitor
nodular regenerative hyperplasia
emtricitabine
emtricitabine/tenofovir
tenofovir alafenamide
efavirenz/emtricitabine/tenofovir
bictegravir/emtricitabine/tenofovir alafenamide
elvitegravir/cobicistat/emtricitabine/tenofovir
tenofovir disoproxil
bictegravir
emtricitabine/rilpivirine/tenofovir
pre-exposure prophylaxis
lamivudine
lamivudine/zidovudine
dolutegravir/lamivudine
abacavir/lamivudine
dolutegravir/lamivudine/tenofovir
lamivudine/raltegravir
abacavir/dolutegravir/lamivudine
lamivudine/tenofovir
doravirine/lamivudine/tenofovir
who model list of essential medicines
stavudine
lamivudine/nevirapine/stavudine
organic anion transporter 1
metaxalone
atc code j05
nucleoside analogue
lipodystrophy
stampidine
reverse-transcriptase inhibitor
adverse effect
tenofovir disoproxil
emtricitabine/tenofovir
tenofovir alafenamide
efavirenz/emtricitabine/tenofovir
bictegravir/emtricitabine/tenofovir alafenamide
elvitegravir/cobicistat/emtricitabine/tenofovir
dolutegravir/lamivudine/tenofovir
emtricitabine
pre-exposure prophylaxis
lamivudine/tenofovir
zidovudine
lamivudine/zidovudine
lamivudine
abacavir/lamivudine/zidovudine
lamivudine/nevirapine/zidovudine
reverse transcriptase
nevirapine
who model list of essential medicines
glucuronidation
list of antiviral drugs
isoniazid
tuberculosis management
isoniazid/rifampicin
who model list of essential medicines
ethambutol/isoniazid
rifampicin/isoniazid/pyrazinamide
ethambutol/isoniazid/pyrazinamide/rifampicin
latent tuberculosis
tuberculosis
isopar
rifampicin
isoniazid/rifampicin
who model list of essential medicines
tuberculosis management
ethambutol/isoniazid/pyrazinamide/rifampicin
leprosy
rifampicin/isoniazid/pyrazinamide
genexpert mtb/rif
tuberculosis
isoniazid
pyrazinamide
who model list of essential medicines
ethambutol/isoniazid/pyrazinamide/rifampicin
streptomycin
rifampicin/isoniazid/pyrazinamide
tuberculosis management
isoniazid
uricosuric
tuberculosis
pnca
ethambutol
who model list of essential medicines
tuberculosis management
ethambutol/isoniazid/pyrazinamide/rifampicin
ethambutol/isoniazid
ethambutol/isoniazid/rifampicin
isoniazid
enantiopure drug
tuberculosis
bacteriostatic agent
risperidone
olanzapine
list of adverse effects of risperidone
paliperidone
fluoxetine
bupropion
quetiapine
potency (pharmacology)
tizanidine
amitriptyline
olanzapine
olanzapine/fluoxetine
olanzapine/samidorphan
atypical antipsychotic
list of adverse effects of olanzapine
psychotic depression
lurasidone
antipsychotic
quetiapine
fluoxetine
quetiapine
antipsychotic
atypical antipsychotic
olanzapine
lurasidone
appetite stimulant
quell
psychotic depression
mirtazapine
obsessive–compulsive disorder
ziprasidone
atypical antipsychotic
potency (pharmacology)
quetiapine
psychomotor agitation
amisulpride
lurasidone
antipsychotic
extrapyramidal symptoms
aripiprazole
paliperidone
risperidone
list of antipsychotics
antipsychotic
atypical antipsychotic
lurasidone
amisulpride
hyperprolactinaemia
neuroleptic-induced deficit syndrome
list of psychotropic medications
lurasidone
cycloserine/lurasidone
list of adverse effects of lurasidone
atypical antipsychotic
extrapyramidal symptoms
antipsychotic
akathisia
5-ht1a receptor
amisulpride
alpha-2 adrenergic receptor
everolimus
novartis
anticonvulsant
pancreatic neuroendocrine tumor
neuroendocrine tumor
targeted therapy
list of largest selling pharmaceutical products
tuberous sclerosis
exemestane
sunitinib
bevacizumab
genentech
novartis
carmen puliafito
anti–vascular endothelial growth factor therapy
chemotherapy
biosimilar
side effect
sue desmond-hellmann
angiogenesis inhibitor
bevacizumab
ranibizumab
folfoxiri
anti–vascular endothelial growth factor therapy
macular degeneration
folfiri
carmen puliafito
angiogenesis inhibitor
atezolizumab
corneal neovascularization
carmustine
nitrosourea
bristol myers squibb
list of drugs: bi-bo
carmustine
eisai (company)
lomustine
nitrosourea
beam
alkylating antineoplastic agent
interstitial lung disease
diffuse intrinsic pontine glioma
methotrexate
cutaneous t cell lymphoma
t.n.t. (album)
ac-to-ac converter
ac/dc
ac-t (disambiguation)
.ac
alternating current
ac cobra
ac/dc discography
a.c.t
lockheed ac-130
product containing abacavir
product containing abacavir and lamivudine and zidovudine
product containing precisely abacavir
product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet
abacavir
abacavir sulfate
product containing abacavir and lamivudine
allergy to abacavir
product containing abacavir and lamivudine in oral dose form
product containing abacavir in oral dose form
product containing abacavir and dolutegravir and lamivudine
product containing abacavir and dolutegravir and lamivudine in oral dose form
product containing abacavir and lamivudine and zidovudine in oral dose form
product containing only abacavir
product containing only abacavir and lamivudine
product containing only abacavir and dolutegravir and lamivudine
product containing only abacavir and lamivudine and zidovudine
product containing only abacavir in oral dose form
product containing only abacavir and lamivudine in oral dose form
product containing only abacavir and dolutegravir and lamivudine in oral dose form
product containing only abacavir and lamivudine and zidovudine in oral dose form
product containing precisely abacavir
product containing precisely abacavir
product containing didanosine
didanosine adverse reaction
allergy to didanosine
product containing precisely didanosine 150 milligram/1 each conventional release oral tablet
product containing precisely didanosine 25 milligram/1 each conventional release oral tablet
product containing precisely didanosine 100 milligram/1 each conventional release oral tablet
product containing precisely didanosine 400 milligram/1 each gastro-resistant oral capsule
product containing precisely didanosine 250 milligram/1 each gastro-resistant oral capsule
product containing precisely didanosine 200 milligram/1 each gastro-resistant oral capsule
product containing precisely didanosine 125 milligram/1 each gastro-resistant oral capsule
product containing precisely didanosine 200 milligram/1 each conventional release oral tablet
product containing precisely didanosine 50 milligram/1 each conventional release oral tablet
product containing precisely didanosine 125 milligram/1 each conventional release oral capsule
product containing precisely didanosine 200 milligram/1 each conventional release oral capsule
product containing precisely didanosine 250 milligram/1 each conventional release oral capsule
didanosine
product containing didanosine in oral dose form
product containing only didanosine
product containing only didanosine in oral dose form
product containing precisely didanosine 2.5 milligram/1 milliliter conventional release oral solution
product containing precisely didanosine 1.67 milligram/1 milliliter conventional release oral solution
product containing precisely didanosine 1 milligram/1 milliliter conventional release oral solution
product containing precisely didanosine 10 milligram/1 milliliter conventional release oral solution
product containing emtricitabine
emtricitabine
product containing precisely emtricitabine 200 milligram/1 each conventional release oral capsule
product containing emtricitabine and tenofovir
product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet
product containing efavirenz and emtricitabine and tenofovir
product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet
product containing emtricitabine and rilpivirine and tenofovir
product containing efavirenz and emtricitabine and tenofovir in oral dose form
product containing emtricitabine and tenofovir in oral dose form
product containing emtricitabine in oral dose form
product containing cobicistat and elvitegravir and emtricitabine and tenofovir
product containing cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form
product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet
product containing precisely emtricitabine 10 milligram/1 milliliter conventional release oral solution
product containing bictegravir and emtricitabine and tenofovir
product containing bictegravir and emtricitabine and tenofovir in oral dose form
product containing only bictegravir and emtricitabine and tenofovir
product containing only cobicistat and elvitegravir and emtricitabine and tenofovir
product containing only efavirenz and emtricitabine and tenofovir
product containing only emtricitabine
product containing only emtricitabine and rilpivirine and tenofovir
product containing only emtricitabine and tenofovir
product containing only bictegravir and emtricitabine and tenofovir in oral dose form
product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form
product containing only efavirenz and emtricitabine and tenofovir in oral dose form
product containing only emtricitabine and tenofovir in oral dose form
product containing only emtricitabine in oral dose form
product containing lamivudine
product containing abacavir and lamivudine and zidovudine
product containing precisely lamivudine 150 milligram/1 each conventional release oral tablet
product containing precisely lamivudine 10 milligram/1 milliliter conventional release oral solution
product containing precisely lamivudine 5 milligram/1 milliliter conventional release oral solution
product containing precisely lamivudine 100 milligram/1 each conventional release oral tablet
product containing lamivudine and zidovudine
product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet
product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet
lamivudine
product containing precisely lamivudine 300 milligram/1 each conventional release oral tablet
product containing abacavir and lamivudine
product containing lamivudine and nevirapine and zidovudine
product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet
product containing lamivudine and stavudine
product containing precisely lamivudine 150 milligram and stavudine 40 milligram/1 each conventional release oral tablet
product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet
product containing precisely lamivudine 150 milligram and stavudine 30 milligram/1 each conventional release oral tablet
product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet
product containing lamivudine and nevirapine and stavudine
product containing precisely lamivudine 30 milligram and zidovudine 60 milligram/1 each conventional release oral tablet
product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 30 milligram/1 each conventional release oral tablet
product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet
product containing abacavir and lamivudine in oral dose form
product containing lamivudine in oral dose form
product containing lamivudine and nevirapine and stavudine in oral dose form
product containing lamivudine and nevirapine and zidovudine in oral dose form
product containing lamivudine and zidovudine in oral dose form
product containing abacavir and dolutegravir and lamivudine
product containing abacavir and dolutegravir and lamivudine in oral dose form
product containing abacavir and lamivudine and zidovudine in oral dose form
product containing only abacavir and lamivudine
product containing only abacavir and dolutegravir and lamivudine
product containing only abacavir and lamivudine and zidovudine
product containing only abacavir and lamivudine in oral dose form
product containing only abacavir and dolutegravir and lamivudine in oral dose form
product containing only abacavir and lamivudine and zidovudine in oral dose form
product containing lamivudine and stavudine in oral dose form
product containing only lamivudine
product containing only lamivudine and nevirapine and stavudine
product containing only lamivudine and nevirapine and zidovudine
product containing only lamivudine and stavudine
product containing only lamivudine and zidovudine
product containing only lamivudine and nevirapine and stavudine in oral dose form
product containing only lamivudine and nevirapine and zidovudine in oral dose form
product containing only lamivudine and stavudine in oral dose form
product containing only lamivudine and zidovudine in oral dose form
product containing only lamivudine in oral dose form
product containing only doravirine and lamivudine and tenofovir
product containing doravirine and lamivudine and tenofovir
product containing doravirine and lamivudine and tenofovir in oral dose form
product containing only doravirine and lamivudine and tenofovir in oral dose form
product containing precisely abacavir
product containing lamivudine and nevirapine and stavudine in oromucosal dose form
product containing only lamivudine and nevirapine and stavudine in oromucosal dose form
product containing dolutegravir and lamivudine
product containing only dolutegravir and lamivudine
product containing dolutegravir and lamivudine in oral dose form
product containing only dolutegravir and lamivudine in oral dose form
product containing stavudine
product containing precisely stavudine 15 milligram/1 each conventional release oral capsule
product containing precisely stavudine 20 milligram/1 each conventional release oral capsule
product containing precisely stavudine 30 milligram/1 each conventional release oral capsule
product containing precisely stavudine 40 milligram/1 each conventional release oral capsule
product containing precisely stavudine 1 milligram/1 milliliter conventional release oral solution
stavudine
product containing lamivudine and stavudine
product containing precisely lamivudine 150 milligram and stavudine 40 milligram/1 each conventional release oral tablet
product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet
product containing precisely lamivudine 150 milligram and stavudine 30 milligram/1 each conventional release oral tablet
product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet
product containing lamivudine and nevirapine and stavudine
product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 30 milligram/1 each conventional release oral tablet
product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet
product containing lamivudine and nevirapine and stavudine in oral dose form
product containing stavudine in oral dose form
product containing lamivudine and stavudine in oral dose form
product containing only lamivudine and nevirapine and stavudine
product containing only lamivudine and stavudine
product containing only stavudine
product containing only lamivudine and nevirapine and stavudine in oral dose form
product containing only lamivudine and stavudine in oral dose form
product containing only stavudine in oral dose form
product containing lamivudine and nevirapine and stavudine in oromucosal dose form
product containing only lamivudine and nevirapine and stavudine in oromucosal dose form
tenofovir disoproxil fumarate
product containing tenofovir
product containing precisely tenofovir disoproxil
product containing emtricitabine and tenofovir
product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet
tenofovir disoproxil
tenofovir
product containing efavirenz and emtricitabine and tenofovir
product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet
product containing emtricitabine and rilpivirine and tenofovir
product containing efavirenz and emtricitabine and tenofovir in oral dose form
product containing emtricitabine and tenofovir in oral dose form
product containing tenofovir in oral dose form
tenofovir alafenamide
product containing cobicistat and elvitegravir and emtricitabine and tenofovir
product containing cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form
product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet
tenofovir alafenamide fumarate
product containing bictegravir and emtricitabine and tenofovir
product containing bictegravir and emtricitabine and tenofovir in oral dose form
product containing only bictegravir and emtricitabine and tenofovir
product containing only cobicistat and elvitegravir and emtricitabine and tenofovir
product containing only efavirenz and emtricitabine and tenofovir
product containing only emtricitabine and rilpivirine and tenofovir
product containing only emtricitabine and tenofovir
product containing only tenofovir
product containing only bictegravir and emtricitabine and tenofovir in oral dose form
product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form
product containing only efavirenz and emtricitabine and tenofovir in oral dose form
product containing only emtricitabine and tenofovir in oral dose form
product containing only tenofovir in oral dose form
product containing only doravirine and lamivudine and tenofovir
product containing doravirine and lamivudine and tenofovir
product containing doravirine and lamivudine and tenofovir in oral dose form
product containing only doravirine and lamivudine and tenofovir in oral dose form
product containing zidovudine
product containing abacavir and lamivudine and zidovudine
zidovudine adverse reaction
allergy to zidovudine
product containing precisely zidovudine 100 milligram/1 each conventional release oral capsule
product containing precisely zidovudine 250 milligram/1 each conventional release oral capsule
product containing lamivudine and zidovudine
product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet
product containing precisely zidovudine 300 milligram/1 each conventional release oral tablet
product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet
zidovudine
product containing lamivudine and nevirapine and zidovudine
product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet
product containing zidovudine in parenteral dose form
product containing zidovudine in oral dose form
product containing precisely lamivudine 30 milligram and zidovudine 60 milligram/1 each conventional release oral tablet
product containing precisely zidovudine 60 milligram/1 each conventional release oral tablet
anemia caused by zidovudine
product containing lamivudine and nevirapine and zidovudine in oral dose form
product containing lamivudine and zidovudine in oral dose form
product containing abacavir and lamivudine and zidovudine in oral dose form
product containing precisely zidovudine 10 milligram/1 milliliter conventional release oral solution
product containing only abacavir and lamivudine and zidovudine
product containing only abacavir and lamivudine and zidovudine in oral dose form
product containing only lamivudine and nevirapine and zidovudine
product containing only lamivudine and zidovudine
product containing only zidovudine
product containing only lamivudine and nevirapine and zidovudine in oral dose form
product containing only lamivudine and zidovudine in oral dose form
product containing only zidovudine in oral dose form
product containing only zidovudine in parenteral dose form
poisoning caused by isoniazid
product containing isoniazid
accidental isoniazid poisoning
intentional isoniazid poisoning
isoniazid poisoning of undetermined intent
isoniazid adverse reaction
allergy to isoniazid
isoniazid overdose
accidental isoniazid overdose
intentional isoniazid overdose
isoniazid overdose of undetermined intent
product containing precisely isoniazid 50 milligram/1 each conventional release oral tablet
product containing precisely isoniazid 100 milligram/1 each conventional release oral tablet
product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet
product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet
product containing isoniazid and rifampicin
product containing isoniazid and pyrazinamide and rifampicin
product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet
product containing precisely isoniazid 300 milligram/1 each conventional release oral tablet
product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral capsule
isoniazid
urine isoniazid measurement
isoniazid resistant tuberculosis
product containing isoniazid in parenteral dose form
product containing isoniazid in oral dose form
neuropathy caused by isoniazid
product containing isoniazid and pyrazinamide and rifampicin in oral dose form
product containing isoniazid and rifampicin in oral dose form
product containing ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form
product containing ethambutol and isoniazid in oral dose form
product containing ethambutol and isoniazid
product containing ethambutol and isoniazid and rifampicin
product containing ethambutol and isoniazid and pyrazinamide and rifampicin
product containing ethambutol and isoniazid and rifampicin in oral dose form
product containing precisely isoniazid 10 milligram/1 milliliter conventional release oral solution
product containing only ethambutol and isoniazid
product containing only ethambutol and isoniazid and pyrazinamide and rifampicin
product containing only ethambutol and isoniazid and rifampicin
product containing only isoniazid
product containing only isoniazid and pyrazinamide and rifampicin
product containing only isoniazid and rifampicin
product containing only ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form
product containing only ethambutol and isoniazid and rifampicin in oral dose form
product containing only ethambutol and isoniazid in oral dose form
product containing only isoniazid and pyrazinamide and rifampicin in oral dose form
product containing only isoniazid and rifampicin in oral dose form
product containing only isoniazid in oral dose form
product containing only isoniazid in parenteral dose form
product containing precisely isoniazid 25 milligram/1 milliliter conventional release solution for injection
product containing rifampicin
rifampicin poisoning
rifampicin adverse reaction
allergy to rifampicin
product containing precisely rifampicin 150 milligram/1 each conventional release oral capsule
product containing precisely rifampicin 300 milligram/1 each conventional release oral capsule
product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet
product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet
product containing isoniazid and rifampicin
product containing isoniazid and pyrazinamide and rifampicin
product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet
rifampicin
urine rifampicin level
rifampicin resistant tuberculosis
product containing rifampicin in oral dose form
product containing rifampicin in parenteral dose form
product containing isoniazid and pyrazinamide and rifampicin in oral dose form
product containing isoniazid and rifampicin in oral dose form
product containing ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form
product containing ethambutol and isoniazid and rifampicin
product containing ethambutol and isoniazid and pyrazinamide and rifampicin
product containing ethambutol and isoniazid and rifampicin in oral dose form
product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral capsule
rifampicin sodium
product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for injection
product containing precisely rifampicin 20 milligram/1 milliliter conventional release oral suspension
product containing only ethambutol and isoniazid and pyrazinamide and rifampicin
product containing only ethambutol and isoniazid and rifampicin
product containing only isoniazid and pyrazinamide and rifampicin
product containing only isoniazid and rifampicin
product containing only rifampicin
product containing only ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form
product containing only ethambutol and isoniazid and rifampicin in oral dose form
product containing only isoniazid and pyrazinamide and rifampicin in oral dose form
product containing only isoniazid and rifampicin in oral dose form
product containing only rifampicin in oral dose form
product containing only rifampicin in parenteral dose form
product containing pyrazinamide
pyrazinamide measurement
pyrazinamide adverse reaction
allergy to pyrazinamide
product containing precisely pyrazinamide 500 milligram/1 each conventional release oral tablet
product containing isoniazid and pyrazinamide and rifampicin
product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet
pyrazinamide
pyrazinamide resistant tuberculosis
product containing isoniazid and pyrazinamide and rifampicin in oral dose form
product containing ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form
product containing pyrazinamide in oral dose form
product containing ethambutol and isoniazid and pyrazinamide and rifampicin
product containing only ethambutol and isoniazid and pyrazinamide and rifampicin
product containing only isoniazid and pyrazinamide and rifampicin
product containing only pyrazinamide
product containing only ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form
product containing only isoniazid and pyrazinamide and rifampicin in oral dose form
product containing only pyrazinamide in oral dose form
poisoning caused by ethambutol
product containing ethambutol
ethambutol hydrochloride
ethambutol measurement
accidental ethambutol poisoning
intentional ethambutol poisoning
ethambutol poisoning of undetermined intent
ethambutol overdose
accidental ethambutol overdose
intentional ethambutol overdose
ethambutol overdose of undetermined intent
product containing precisely ethambutol hydrochloride 100 milligram/1 each conventional release oral tablet
product containing precisely ethambutol hydrochloride 400 milligram/1 each conventional release oral tablet
ethambutol
urine ethambutol level
ethambutol adverse reaction
ethambutol resistant tuberculosis
product containing ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form
product containing ethambutol and isoniazid in oral dose form
product containing ethambutol and isoniazid
product containing ethambutol in oral dose form
product containing ethambutol and isoniazid and rifampicin
product containing ethambutol and isoniazid and pyrazinamide and rifampicin
product containing ethambutol and isoniazid and rifampicin in oral dose form
product containing only ethambutol
product containing only ethambutol and isoniazid
product containing only ethambutol and isoniazid and pyrazinamide and rifampicin
product containing only ethambutol and isoniazid and rifampicin
product containing only ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form
product containing only ethambutol and isoniazid and rifampicin in oral dose form
product containing only ethambutol and isoniazid in oral dose form
product containing only ethambutol in oral dose form
allergy to ethambutol
product containing risperidone
risperidone measurement
risperidone poisoning
accidental risperidone poisoning
intentional risperidone poisoning
risperidone poisoning of undetermined intent
risperidone adverse reaction
allergy to risperidone
risperidone overdose
accidental risperidone overdose
intentional risperidone overdose
risperidone overdose of undetermined intent
product containing precisely risperidone 1 milligram/1 each conventional release oral tablet
product containing precisely risperidone 2 milligram/1 each conventional release oral tablet
product containing precisely risperidone 3 milligram/1 each conventional release oral tablet
product containing precisely risperidone 4 milligram/1 each conventional release oral tablet
product containing precisely risperidone 1 milligram/1 milliliter conventional release oral solution
product containing precisely risperidone 6 milligram/1 each conventional release oral tablet
product containing precisely risperidone 500 microgram/1 each conventional release oral tablet
product containing precisely risperidone 250 microgram/1 each conventional release oral tablet
risperidone
product containing risperidone in oral dose form
product containing risperidone in parenteral dose form
product containing precisely risperidone 1 milligram/1 each conventional release orodispersible tablet
product containing precisely risperidone 2 milligram/1 each conventional release orodispersible tablet
product containing precisely risperidone 500 microgram/1 each conventional release orodispersible tablet
product containing precisely risperidone 3 milligram/1 each conventional release orodispersible tablet
product containing precisely risperidone 4 milligram/1 each conventional release orodispersible tablet
product containing precisely risperidone 12.5 milligram/1 vial powder for conventional release suspension for injection
product containing precisely risperidone 25 milligram/1 vial powder for conventional release suspension for injection
product containing precisely risperidone 37.5 milligram/1 vial powder for conventional release suspension for injection
product containing precisely risperidone 50 milligram/1 vial powder for conventional release suspension for injection
product containing only risperidone
product containing only risperidone in oral dose form
product containing only risperidone in parenteral dose form
product containing risperidone in oromucosal dose form
product containing only risperidone in oromucosal dose form
product containing olanzapine
olanzapine measurement
product containing precisely olanzapine 5 milligram/1 each conventional release oral tablet
product containing precisely olanzapine 7.5 milligram/1 each conventional release oral tablet
product containing precisely olanzapine 10 milligram/1 each conventional release oral tablet
product containing precisely olanzapine 2.5 milligram/1 each conventional release oral tablet
product containing precisely olanzapine 5 milligram/1 each conventional release orodispersible tablet
product containing precisely olanzapine 10 milligram/1 each conventional release orodispersible tablet
product containing precisely olanzapine 20 milligram/1 each conventional release oral tablet
product containing precisely olanzapine 15 milligram/1 each conventional release oral tablet
product containing precisely olanzapine 20 milligram/1 each conventional release orodispersible tablet
olanzapine
product containing precisely olanzapine 15 milligram/1 each conventional release orodispersible tablet
product containing fluoxetine and olanzapine
product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule
product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 6 milligram/1 each conventional release oral capsule
product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule
product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule
product containing olanzapine in parenteral dose form
product containing olanzapine in oral dose form
product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule
olanzapine embonate
olanzapine embonate monohydrate
olanzapine pamoate
product containing fluoxetine and olanzapine in oral dose form
product containing only fluoxetine and olanzapine
product containing only olanzapine
product containing only fluoxetine and olanzapine in oral dose form
product containing only olanzapine in oral dose form
product containing only olanzapine in parenteral dose form
product containing olanzapine in oromucosal dose form
product containing only olanzapine in oromucosal dose form
quetiapine fumarate
product containing quetiapine
product containing precisely quetiapine
product containing precisely quetiapine
product containing precisely quetiapine
quetiapine
product containing precisely quetiapine
product containing precisely quetiapine
product containing precisely quetiapine
measurement of quetiapine
product containing precisely quetiapine
product containing precisely quetiapine fumarate 400 milligram/1 each conventional release oral tablet
product containing precisely quetiapine fumarate 50 milligram/1 each conventional release oral tablet
product containing quetiapine in oral dose form
product containing only quetiapine
product containing only quetiapine in oral dose form
product containing precisely quetiapine
ziprasidone hydrochloride
product containing ziprasidone
product containing precisely ziprasidone
product containing precisely ziprasidone hydrochloride 40 milligram/1 each conventional release oral capsule
product containing precisely ziprasidone
product containing precisely ziprasidone hydrochloride 80 milligram/1 each conventional release oral capsule
ziprasidone
ziprasidone mesilate
product containing ziprasidone in parenteral dose form
product containing ziprasidone in oral dose form
product containing only ziprasidone
product containing only ziprasidone in oral dose form
product containing only ziprasidone in parenteral dose form
product containing precisely ziprasidone
paliperidone
product containing paliperidone
product containing precisely paliperidone 3 milligram/1 each prolonged-release oral tablet
product containing precisely paliperidone 6 milligram/1 each prolonged-release oral tablet
product containing precisely paliperidone 9 milligram/1 each prolonged-release oral tablet
product containing precisely paliperidone 1.5 milligram/1 each prolonged-release oral tablet
paliperidone palmitate
product containing only paliperidone
product containing paliperidone in oral dose form
product containing only paliperidone in oral dose form
lurasidone hydrochloride
lurasidone
product containing lurasidone
product containing lurasidone in oral dose form
product containing only lurasidone
product containing only lurasidone in oral dose form
product containing bevacizumab
bevacizumab
product containing bevacizumab in parenteral dose form
product containing only bevacizumab
product containing only bevacizumab in parenteral dose form
product containing precisely bevacizumab 25 milligram/1 milliliter conventional release solution for injection
product containing carmustine
carmustine poisoning
accidental carmustine poisoning
intentional carmustine poisoning
carmustine poisoning of undetermined intent
carmustine adverse reaction
allergy to carmustine
carmustine overdose
accidental carmustine overdose
intentional carmustine overdose
carmustine overdose of undetermined intent
carmustine
implantation of carmustine wafer into cerebrum
product containing precisely carmustine 100 milligram/1 vial powder for conventional release solution for injection
product containing carmustine in parenteral dose form
product containing only carmustine
product containing only carmustine in parenteral dose form
product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant
product containing carmustine in prolonged-release intralesional implant
product containing only carmustine in prolonged-release intralesional implant

